Map of Comprehensive Medicaid Coverage of Treatments (Lung Association Cessation Coverage)

2008-2022. American Lung Association. Cessation Coverage – Comprehensive Medicaid Coverage of Treatments. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on comprehensive Medicaid coverage of all approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment and types of counseling recommended by the Public Health Service (PHS). Approved medications by the FDA include: Nicotine patch, Nicotine gum, Nicotine lozenge, Nicotine nasal spray, Nicotine inhaler, Bupropion (Zyban) and Varenicline (Chantix). The types of counseling recommended by the PHS are: individual counseling, group counseling and phone counseling. Data do not include phone counseling which is available in every state through quitlines.